Global Drugs for the Treatment of Asthma Market Research Report to 2021

November 2016 | 106 pages | ID: GF1831A3B1BEN
QYResearch

Abstracts

Notes:

Production, means the output of Drugs for the Treatment of Asthma

Revenue, means the sales value of Drugs for the Treatment of Asthma

This report studies Drugs for the Treatment of Asthma in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Novartis
• Pfizer, Inc.
• Roche
• Sanofi
• Merck & Co., Inc.
• GlaxoSmithKline plc
• Johnson & Johnson
• AstraZeneca plc.
• Eli Lilly and Company
• Abbvie
• AMGen
• Teva Pharmaceutical Industries Ltd.
• Bayer AG
• Bristol-Myers Squibb
• Astellas Pharma
• Daiichi Sankyo
• Abbott Laboratories
• Yangtze River Pharmaceutical Group
• BAX
• Taishō Seiyaku Kabushiki-gaisha

Market Segment by Regions, this report splits Global into several key Region, with production, consumption, revenue, market share and growth rate of Drugs for the Treatment of Asthma in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Beta2 Adrenergic Receptor Agonist
• M Cholinergic Receptor Antagonist
• Drugs that Affect Leukotrienes
• Glucocorticoid Drugs
• Phosphodiesterase Inhibitors

Split by application, this report focuses on consumption, market share and growth rate of Drugs for the Treatment of Asthma in each application, can be divided into

• First Level Hospital
• Two Level Hospital
• Three Level Hospital
• Others

Contents

Global Drugs for the Treatment of Asthma Market Research Report 2021

1 DRUGS FOR THE TREATMENT OF ASTHMA OVERVIEW

1.1 Product Overview and Scope of Drugs for the Treatment of Asthma
1.2 Drugs for the Treatment of Asthma Segment by Types
  1.2.1 Global Production Market Share of Drugs for the Treatment of Asthma by Type in 2015
  1.2.2 Beta2 Adrenergic Receptor Agonist Overview and Price
    1.2.2.1 Beta2 Adrenergic Receptor Agonist Overview
    1.2.2.2 Beta2 Adrenergic Receptor Agonist Price List in 2015 and 2016
  1.2.3 M Cholinergic Receptor Antagonist
    1.2.3.1 M Cholinergic Receptor Antagonist Overview
    1.2.3.2 M Cholinergic Receptor Antagonist Price List in 2015 and 2016
  1.2.4 Drugs that Affect Leukotrienes
    1.2.4.1 Drugs that Affect Leukotrienes Overview
    1.2.4.2 Drugs that Affect Leukotrienes Price List in 2015 and 2016
  1.2.5 Glucocorticoid Drugs
    1.2.5.1 Glucocorticoid Drugs Overview
    1.2.5.2 Glucocorticoid Drugs Price List in 2015 and 2016
  1.2.6 Phosphodiesterase Inhibitors
    1.2.6.1 Phosphodiesterase Inhibitors Overview
    1.2.6.2 Phosphodiesterase Inhibitors Price List in 2015 and 2016
1.3 Drugs for the Treatment of Asthma Segment by Application
  1.3.1 Drugs for the Treatment of Asthma Consumption Market Share by Application in 2015
  1.3.2 First Level Hospital and Major Clients (Buyers) List
  1.3.3 Two Level Hospital and Major Clients (Buyers) List
  1.3.4 Three Level Hospital and Major Clients (Buyers) List
  1.3.5 Others and Major Clients (Buyers) List
1.4 Drugs for the Treatment of Asthma Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Drugs for the Treatment of Asthma (2011-2021)
  1.5.1 Global Drugs for the Treatment of Asthma Production and Revenue (2011-2021)
  1.5.2 Global Drugs for the Treatment of Asthma Production and Growth Rate (2011-2021)
  1.5.3 Global Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)

2 GLOBAL DRUGS FOR THE TREATMENT OF ASTHMA MARKET COMPETITION BY MANUFACTURERS

2.1 Global Drugs for the Treatment of Asthma Production and Share by Manufacturers (2015 and 2016)
2.2 Global Drugs for the Treatment of Asthma Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Drugs for the Treatment of Asthma Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Drugs for the Treatment of Asthma Manufacturing Base Distribution and Product Type
2.5 Competitive Situation and Trends
  2.5.1 Expansions
  2.5.2 New Product Launches
  2.5.3 Acquisitions
  2.5.4 Other Developments

3 GLOBAL DRUGS FOR THE TREATMENT OF ASTHMA ANALYSIS BY REGION

3.1 Global Drugs for the Treatment of Asthma Production, Revenue and Market Share by Region (2011-2021)
  3.1.1 Global Drugs for the Treatment of Asthma Production Market Share by Region (2011-2021)
  3.1.2 Global Drugs for the Treatment of Asthma Revenue Market Share by Region (2011-2021)
3.2 Global Drugs for the Treatment of Asthma Consumption by Region (2011-2021)
3.3 North America
  3.3.1 North America Drugs for the Treatment of Asthma Production, Revenue and Price (2011-2021)
  3.3.2 North America Drugs for the Treatment of Asthma Production, Revenue and Growth Rate (2011-2021)
3.4 Europe
  3.4.1 Europe Drugs for the Treatment of Asthma Production, Revenue and Price (2011-2021)
  3.4.2 Europe Drugs for the Treatment of Asthma Production, Revenue and Growth Rate (2011-2021)
3.5 China
  3.5.1 China Drugs for the Treatment of Asthma Production, Revenue and Price (2011-2021)
  3.5.2 China Drugs for the Treatment of Asthma Production, Revenue and Growth Rate (2011-2021)
3.6 Japan
  3.6.1 Japan Drugs for the Treatment of Asthma Production, Revenue and Price (2011-2021)
  3.6.2 Japan Drugs for the Treatment of Asthma Production, Revenue and Growth Rate (2011-2021)
3.7 India
  3.7.1 India Drugs for the Treatment of Asthma Production, Revenue and Price (2011-2021)
  3.7.2 India Drugs for the Treatment of Asthma Production, Revenue and Growth Rate (2011-2021)
3.8 Southeast Asia
  3.8.1 Southeast Asia Drugs for the Treatment of Asthma Production, Revenue and Price (2011-2021)
  3.8.2 Southeast Asia Drugs for the Treatment of Asthma Production, Revenue and Growth Rate (2011-2021)

4 GLOBAL DRUGS FOR THE TREATMENT OF ASTHMA ANALYSIS BY TYPE

4.1 Global Drugs for the Treatment of Asthma Production, Revenue, Market Share and Growth Rate by Type (2011-2021)
  4.1.1 Global Drugs for the Treatment of Asthma Production and Market Share by Type (2011-2021)
  4.1.2 Global Drugs for the Treatment of Asthma Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 Beta2 Adrenergic Receptor Agonist Production, Revenue, Price and Growth (2011-2021)
4.3 M Cholinergic Receptor Antagonist Production, Revenue, Price and Growth (2011-2021)
4.4 Drugs that Affect Leukotrienes Production, Revenue, Price and Growth (2011-2021)
4.5 Glucocorticoid Drugs Production, Revenue, Price and Growth (2011-2021)
4.6 Phosphodiesterase Inhibitors Production, Revenue, Price and Growth (2011-2021)

5 GLOBAL DRUGS FOR THE TREATMENT OF ASTHMA MARKET ANALYSIS BY APPLICATION

5.1 Global Drugs for the Treatment of Asthma Consumption and Market Share by Application (2011-2021)
5.2 Major Regions Drugs for the Treatment of Asthma Consumption by Application in 2015 and 2016
  5.2.1 North America Drugs for the Treatment of Asthma Consumption by Application
  5.2.2 Europe Drugs for the Treatment of Asthma Consumption by Application
  5.2.3 China Drugs for the Treatment of Asthma Consumption by Application
  5.2.4 Japan Drugs for the Treatment of Asthma Consumption by Application
  5.2.5 India Drugs for the Treatment of Asthma Consumption by Application
  5.2.6 Southeast Asia Drugs for the Treatment of Asthma Consumption by Application
5.3 Global Drugs for the Treatment of Asthma Consumption Growth Rate by Application (2011-2021)
5.4 Market Drivers and Opportunities
  5.4.1 Potential Applications
  5.4.2 Emerging Markets/Countries

6 GLOBAL DRUGS FOR THE TREATMENT OF ASTHMA MANUFACTURERS ANALYSIS

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Drugs for the Treatment of Asthma Product Type and Technology
    6.1.2.1 Beta2 Adrenergic Receptor Agonist
    6.1.2.2 M Cholinergic Receptor Antagonist
    6.1.2.3 Drugs that Affect Leukotrienes
  6.1.3 Pharmaceuticals Production, Revenue, Price of Drugs for the Treatment of Asthma (2015 and 2016)
6.2 Pfizer, Inc.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Drugs for the Treatment of Asthma Product Type and Technology
    6.2.2.1 Beta2 Adrenergic Receptor Agonist
    6.2.2.2 M Cholinergic Receptor Antagonist
    6.2.2.3 Drugs that Affect Leukotrienes
  6.2.3 Pfizer, Inc. Production, Revenue, Price of Drugs for the Treatment of Asthma (2015 and 2016)
6.3 Roche
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Drugs for the Treatment of Asthma Product Type and Technology
    6.3.2.1 Beta2 Adrenergic Receptor Agonist
    6.3.2.2 M Cholinergic Receptor Antagonist
    6.3.2.3 Drugs that Affect Leukotrienes
  6.3.3 Roche Production, Revenue, Price of Drugs for the Treatment of Asthma (2015 and 2016)
6.4 Sanofi
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Drugs for the Treatment of Asthma Product Type and Technology
    6.4.2.1 Beta2 Adrenergic Receptor Agonist
    6.4.2.2 M Cholinergic Receptor Antagonist
  6.4.3 Sanofi Production, Revenue, Price of Drugs for the Treatment of Asthma (2015 and 2016)
6.5 Merck & Co., Inc.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Drugs for the Treatment of Asthma Product Type and Technology
    6.5.2.1 Beta2 Adrenergic Receptor Agonist
    6.5.2.2 M Cholinergic Receptor Antagonist
  6.5.3 Merck & Co., Inc. Production, Revenue, Price of Drugs for the Treatment of Asthma (2015 and 2016)
6.6 GlaxoSmithKline plc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Drugs for the Treatment of Asthma Product Type and Technology
    6.6.2.1 Beta2 Adrenergic Receptor Agonist
    6.6.2.2 M Cholinergic Receptor Antagonist
  6.6.3 GlaxoSmithKline plc Production, Revenue, Price of Drugs for the Treatment of Asthma (2015 and 2016)
6.7 Johnson & Johnson
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Drugs for the Treatment of Asthma Product Type and Technology
    6.7.2.1 Beta2 Adrenergic Receptor Agonist
    6.7.2.2 M Cholinergic Receptor Antagonist
  6.7.3 Johnson & Johnson Production, Revenue, Price of Drugs for the Treatment of Asthma (2015 and 2016)
6.8 AstraZeneca plc.
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Drugs for the Treatment of Asthma Product Type and Technology
    6.8.2.1 Beta2 Adrenergic Receptor Agonist
    6.8.2.2 M Cholinergic Receptor Antagonist
  6.8.3 AstraZeneca plc. Production, Revenue, Price of Drugs for the Treatment of Asthma (2015 and 2016)
6.9 Eli Lilly and Company
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Drugs for the Treatment of Asthma Product Type and Technology
    6.9.2.1 Beta2 Adrenergic Receptor Agonist
    6.9.2.2 M Cholinergic Receptor Antagonist
  6.9.3 Eli Lilly and Company Production, Revenue, Price of Drugs for the Treatment of Asthma (2015 and 2016)
6.10 Abbvie
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Drugs for the Treatment of Asthma Product Type and Technology
    6.10.2.1 Beta2 Adrenergic Receptor Agonist
    6.10.2.2 M Cholinergic Receptor Antagonist
  6.10.3 Abbvie Production, Revenue, Price of Drugs for the Treatment of Asthma (2015 and 2016)
6.11 AMGen
6.12 Teva Pharmaceutical Industries Ltd.
6.13 Bayer AG
6.14 Bristol-Myers Squibb
6.15 Astellas Pharma
6.16 Daiichi Sankyo
6.17 Abbott Laboratories
6.18 Yangtze River Pharmaceutical Group
6.19 BAX
6.20 Taishō Seiyaku Kabushiki-gaisha

7 DRUGS FOR THE TREATMENT OF ASTHMA TECHNOLOGY AND DEVELOPMENT TREND

7.1 Drugs for the Treatment of Asthma Technology Analysis
7.2 Drugs for the Treatment of Asthma Technology Development Trend

8 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Drugs for the Treatment of Asthma
Figure Global Production Market Share of Drugs for the Treatment of Asthma by Type in 2015
Table Drugs for the Treatment of Asthma Product Types of by Manufacturers
Figure Product Picture of Beta2 Adrenergic Receptor Agonist
Table Beta2 Adrenergic Receptor Agonist Price List in 2015 and 2016
Figure Product Picture of M Cholinergic Receptor Antagonist
Table M Cholinergic Receptor Antagonist Price List in 2015 and 2016
Figure Product Picture of Drugs that Affect Leukotrienes
Table Drugs that Affect Leukotrienes Price List in 2015 and 2016
Figure Product Picture of Glucocorticoid Drugs
Table Glucocorticoid Drugs Price List in 2015 and 2016
Figure Product Picture of Phosphodiesterase Inhibitors
Table Phosphodiesterase Inhibitors Price List in 2015 and 2016
Table Drugs for the Treatment of Asthma Consumption Market Share by Applications in 2015 and 2016
Table Drugs for the Treatment of Asthma Major Clients (Buyers) List in First Level Hospital
Table Drugs for the Treatment of Asthma Major Clients (Buyers) List in Two Level Hospital
Table Drugs for the Treatment of Asthma Major Clients (Buyers) List in Three Level Hospital
Table Drugs for the Treatment of Asthma Major Clients (Buyers) List in Others
Figure North America Drugs for the Treatment of Asthma Production and Growth Rate (2011-2021)
Figure North America Drugs for the Treatment of Asthma Consumption and Growth Rate (2011-2021)
Figure China Drugs for the Treatment of Asthma Production and Growth Rate (2011-2021)
Figure China Drugs for the Treatment of Asthma Consumption and Growth Rate (2011-2021)
Figure Europe Drugs for the Treatment of Asthma Production and Growth Rate (2011-2021)
Figure Europe Drugs for the Treatment of Asthma Consumption and Growth Rate (2011-2021)
Figure Japan Drugs for the Treatment of Asthma Production and Growth Rate (2011-2021)
Figure Japan Drugs for the Treatment of Asthma Consumption and Growth Rate (2011-2021)
Figure India Drugs for the Treatment of Asthma Production and Growth Rate (2011-2021)
Figure India Drugs for the Treatment of Asthma Consumption and Growth Rate (2011-2021)
Figure Southeast Asia Drugs for the Treatment of Asthma Production and Growth Rate (2011-2021)
Figure Southeast Asia Drugs for the Treatment of Asthma Consumption and Growth Rate (2011-2021)
Table Global Drugs for the Treatment of Asthma Production and Revenue (2011-2021)
Figure Global Drugs for the Treatment of Asthma Production and Growth Rate (2011-2021)
Figure Global Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Table Global Drugs for the Treatment of Asthma Production of Key Manufacturers (2015 and 2016)
Table Global Drugs for the Treatment of Asthma Production Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for the Treatment of Asthma Production Share by Manufacturers
Figure 2016 Drugs for the Treatment of Asthma Production Share by Manufacturers
Table Global Drugs for the Treatment of Asthma Revenue by Manufacturers (2015 and 2016)
Table Global Drugs for the Treatment of Asthma Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Drugs for the Treatment of Asthma Revenue Share by Manufacturers
Table 2016 Global Drugs for the Treatment of Asthma Revenue Share by Manufacturers
Table Global Market Drugs for the Treatment of Asthma Average Price of Key Manufacturers (2015 and 2016)
Table Manufacturers Drugs for the Treatment of Asthma Manufacturing Base Distribution and Product Type
Table Global Drugs for the Treatment of Asthma Production Market by Region (2011-2021)
Figure Global Drugs for the Treatment of Asthma Production Market by Region (2011-2021)
Figure Global Drugs for the Treatment of Asthma Production Market Share by Region (2011-2021)
Table Global Drugs for the Treatment of Asthma Revenue Market by Region (2011-2021)
Table Global Drugs for the Treatment of Asthma Revenue Market Share by Region (2011-2021)
Table Global Drugs for the Treatment of Asthma Consumption Market by Region (2011-2021)
Table Global Drugs for the Treatment of Asthma Consumption Market Share by Region (2011-2021)
Figure Global Drugs for the Treatment of Asthma Consumption Market Share by Region (2011-2021)
Table North America Drugs for the Treatment of Asthma Production, Revenue and Price (2011-2021)
Figure North America Drugs for the Treatment of Asthma Production, Revenue and Growth Rate (2011-2021)
Table Europe Drugs for the Treatment of Asthma Production, Revenue and Price (2011-2021)
Figure Europe Drugs for the Treatment of Asthma Production, Revenue and Growth Rate (2011-2021)
Table China Drugs for the Treatment of Asthma Production, Revenue and Price (2011-2021)
Figure China Drugs for the Treatment of Asthma Production, Revenue and Growth Rate (2011-2021)
Table Japan Drugs for the Treatment of Asthma Production, Revenue and Price (2011-2021)
Figure Japan Drugs for the Treatment of Asthma Production, Revenue and Growth Rate (2011-2021)
Table India Drugs for the Treatment of Asthma Production, Revenue and Price (2011-2021)
Figure India Drugs for the Treatment of Asthma Production, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Drugs for the Treatment of Asthma Production, Revenue and Price (2011-2021)
Figure Southeast Asia Drugs for the Treatment of Asthma Production, Revenue and Growth Rate (2011-2021)
Table Global Drugs for the Treatment of Asthma Production by Type (2011-2021)
Table Global Drugs for the Treatment of Asthma Production Share by Type (2011-2021)
Figure Production Market Share of Drugs for the Treatment of Asthma by Type (2011-2021)
Figure Global Drugs for the Treatment of Asthma Production Growth Rate by Type (2011-2021)
Table Global Drugs for the Treatment of Asthma Revenue by Type (2011-2021)
Table Global Drugs for the Treatment of Asthma Revenue Share by Type (2011-2021)
Figure Global Drugs for the Treatment of Asthma Revenue Growth Rate by Type (2011-2021)
Figure Beta2 Adrenergic Receptor Agonist Production, Revenue and Growth (2011-2021)
Figure Beta2 Adrenergic Receptor Agonist Price Trend (2011-2021)
Figure M Cholinergic Receptor Antagonist Production, Revenue and Growth (2011-2021)
Figure M Cholinergic Receptor Antagonist Price Trend (2011-2021)
Figure Drugs that Affect Leukotrienes Production, Revenue and Growth (2011-2021)
Figure Drugs that Affect Leukotrienes Price Trend (2011-2021)
Figure Glucocorticoid Drugs Production, Revenue and Growth (2011-2021)
Figure Glucocorticoid Drugs Price Trend (2011-2021)
Figure Phosphodiesterase Inhibitors Production, Revenue and Growth (2011-2021)
Figure Phosphodiesterase Inhibitors Price Trend (2011-2021)
Table Global Drugs for the Treatment of Asthma Consumption by Application (2011-2021)
Table Global Drugs for the Treatment of Asthma Consumption Market Share by Application (2011-2021)
Figure Global Drugs for the Treatment of Asthma Consumption Market Share by Application in 2015
Figure Global Drugs for the Treatment of Asthma Consumption Market Share by Application in 2021
Table North America Drugs for the Treatment of Asthma Consumption by Application (2015 and 2016)
Table Europe Drugs for the Treatment of Asthma Consumption by Application (2015 and 2016)
Table China Drugs for the Treatment of Asthma Consumption by Application (2015 and 2016)
Table Japan Drugs for the Treatment of Asthma Consumption by Application (2015 and 2016)
Table India Drugs for the Treatment of Asthma Consumption by Application (2015 and 2016)
Table Southeast Asia Drugs for the Treatment of Asthma Consumption by Application (2015 and 2016)
Table Global Drugs for the Treatment of Asthma Consumption Growth Rate by Application (2011-2021)
Figure Global Drugs for the Treatment of Asthma Consumption Growth Rate by Application (2011-2021)
Table Novartis Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of Novartis (2015 and 2016)
Table Pfizer, Inc. Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of Pfizer, Inc. (2015 and 2016)
Table Roche Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of Roche (2015 and 2016)
Table Sanofi Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of Sanofi (2015 and 2016)
Table Merck & Co., Inc. Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
Table GlaxoSmithKline plc Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table AstraZeneca plc. Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of AstraZeneca plc. (2015 and 2016)
Table Eli Lilly and Company Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of Eli Lilly and Company (2015 and 2016)
Table Abbvie Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of Abbvie (2015 and 2016)
Table AMGen Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of AMGen (2015 and 2016)
Table Teva Pharmaceutical Industries Ltd. Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of Teva Pharmaceutical Industries Ltd. (2015 and 2016)
Table Bayer AG Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of Bayer AG (2015 and 2016)
Table Bristol-Myers Squibb Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
Table Astellas Pharma Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of Astellas Pharma (2015 and 2016)
Table Daiichi Sankyo Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of Daiichi Sankyo (2015 and 2016)
Table Abbott Laboratories Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of Abbott Laboratories (2015 and 2016)
Table Yangtze River Pharmaceutical Group Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of Yangtze River Pharmaceutical Group (2015 and 2016)
Table BAX Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of BAX (2015 and 2016)
Table Taishō Seiyaku Kabushiki-gaisha Basic Information List
Table Drugs for the Treatment of Asthma Production, Revenue, Price of Taishō Seiyaku Kabushiki-gaisha (2015 and 2016)